Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
47.00
+0.42 (0.90%)
Nov 21, 2024, 1:14 PM EST - Market open
Tarsus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -134.34 | -135.89 | -62.09 | -13.83 | -26.81 | -4.67 | Upgrade
|
| Depreciation & Amortization | 1.14 | 0.88 | 0.33 | 0.31 | 0.1 | 0.07 | Upgrade
|
| Other Amortization | 0.46 | 0.39 | 0.31 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.07 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.69 | -3.42 | -1.05 | 0.59 | - | - | Upgrade
|
| Stock-Based Compensation | 25.9 | 19.83 | 13.46 | 8.46 | 0.84 | 0.02 | Upgrade
|
| Other Operating Activities | 2.59 | 0.42 | 0.97 | 6.78 | 3.28 | 0.42 | Upgrade
|
| Change in Accounts Receivable | -23.8 | -16.62 | - | - | 0.02 | -0.03 | Upgrade
|
| Change in Inventory | -5.37 | -3.11 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 33.35 | 13.24 | 0.82 | 3.88 | 3.24 | 0.25 | Upgrade
|
| Change in Other Net Operating Assets | 2.57 | 6.79 | -1.77 | -2.51 | -1.8 | 0.27 | Upgrade
|
| Operating Cash Flow | -100.18 | -117.49 | -49.03 | 3.75 | -21.14 | -3.67 | Upgrade
|
| Capital Expenditures | -1.5 | -1.5 | -0.51 | -0.59 | -0.46 | -0.18 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -4 | - | - | - | - | Upgrade
|
| Investment in Securities | -120.28 | 146.11 | -144.12 | - | - | - | Upgrade
|
| Investing Cash Flow | -121.77 | 140.6 | -144.63 | -0.59 | -0.46 | -0.18 | Upgrade
|
| Long-Term Debt Issued | - | 10 | 20 | - | - | 1.99 | Upgrade
|
| Net Debt Issued (Repaid) | 75 | 10 | 20 | - | - | 1.99 | Upgrade
|
| Issuance of Common Stock | 122.52 | 120.18 | 74.94 | 0.32 | 92.04 | - | Upgrade
|
| Other Financing Activities | -26.04 | - | -0.95 | -0.3 | - | - | Upgrade
|
| Financing Cash Flow | 171.49 | 130.18 | 93.99 | 0.02 | 131.77 | 59.45 | Upgrade
|
| Net Cash Flow | -50.46 | 153.29 | -99.67 | 3.18 | 110.18 | 55.6 | Upgrade
|
| Free Cash Flow | -101.68 | -119 | -49.54 | 3.16 | -21.59 | -3.85 | Upgrade
|
| Free Cash Flow Margin | -78.44% | -682.04% | -191.88% | 5.54% | - | - | Upgrade
|
| Free Cash Flow Per Share | -2.80 | -4.05 | -2.01 | 0.15 | -3.48 | -1.63 | Upgrade
|
| Cash Interest Paid | 6.33 | 2.88 | 1.68 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -51.32 | -74.49 | -27.35 | 4.74 | -14.49 | -2.31 | Upgrade
|
| Unlevered Free Cash Flow | -47.69 | -72.78 | -26.29 | 4.74 | -14.49 | -2.24 | Upgrade
|
| Change in Net Working Capital | -14.64 | -1.49 | 0.37 | -4.15 | -1.9 | -0.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.